Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor

• Published in: American journal of physiology. Heart and circulatory physiology Vol. 320; no. 1; pp. H169 - H180
• Main Authors: DuPont, Jennifer J., Kim, Seung Kyum, Kenney, Rachel M., Jaffe, Iris Z.
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.01.2021
• Series: Integrative Cardiovascular Physiology and Pathophysiology
• Subjects: Age; Age Factors; Aging; Aging - metabolism; Angiotensin AT1 receptors; Angiotensin II; Animals; Aorta; Blood pressure; Blood vessels; Cardiovascular diseases; Cardiovascular Diseases - genetics; Cardiovascular Diseases - metabolism; Cardiovascular Diseases - physiopathology; Cardiovascular Diseases - prevention & control; Clonal deletion; Female; Females; Fibrosis; Gender aspects; Gender differences; Health risks; Heart diseases; Male; Males; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid receptors; Muscle, Smooth, Vascular - metabolism; Muscle, Smooth, Vascular - physiopathology; Muscles; Myocardium - metabolism; Receptors; Receptors, Mineralocorticoid - genetics; Receptors, Mineralocorticoid - metabolism; Sex; Sex differences; Sex Factors; Sexes; Sexual dimorphism; Signal Transduction; Smooth muscle; Stiffening; Stiffness; Time Factors; Vascular Remodeling; Vascular Stiffness; Vasoconstriction; Wave velocity; cardiovascular disease; mineralocorticoid receptor; vascular aging; sex differences
• ISSN: 0363-6135; 1522-1539; 1522-1539
• DOI: 10.1152/ajpheart.00262.2020

These data demonstrate that the delayed and steeper decline in cardiovascular function observed in aging females can be modeled in aging mice. Moreover, the mechanisms driving vascular and cardiac aging phenotypes are distinct between males and females. Mineralocorticoid receptors in smooth muscle cells play a significant role in cardiovascular aging in both sexes; however, they do so by distinct mechanisms. Overall, these findings suggest that sex-specific therapies may be necessary to retard the aging process and improve cardiovascular disease outcomes in the aging population. Aging is associated with heart and vascular dysfunction that contributes to cardiovascular disease (CVD) risk. Clinical data support a sexual dimorphism in the time course of aging-associated CVD. However, the mechanisms driving sex differences in cardiovascular aging and whether they can be modeled in mice have not been explored. Mineralocorticoid receptors (MRs) regulate blood pressure, and we previously demonstrated in male mice that MR expression increases in aging mouse vessels and smooth muscle cell-specific MR deletion (SMC-MR-KO) protects from cardiovascular aging. This study characterizes sex differences in murine cardiovascular aging and the associated sex-specific role of SMC-MR. Aortic stiffness, measured by pulse wave velocity, increased from 3 to 12 mo of age in males but not until 18 mo in females. The timing of the rise in aortic stiffening correlated with the timing of increased aortic MR expression, and aortic stiffness did not increase with age in SMC-MR-KO mice of both sexes. Vascular fibrosis increased at 12 mo in males and later at 18 mo in females; however, fibrosis was attenuated by SMC-MR-KO in males only. In resistance vessels, angiotensin type 1 receptor (AT 1 R)-mediated vasoconstriction also increased at 12 mo in males and 18 mo in females. ANG II-induced vasoconstriction was decreased in SMC-MR-KO specifically in males in association with decreased AT 1 R expression. Cardiac systolic function declined in males and females by 18 mo of age, which was prevented by SMC-MR-KO specifically in females. Cardiac perivascular fibrosis increased with age in both sexes accompanied by sex-specific changes in the expression levels of MR-regulated profibrotic genes. NEW & NOTEWORTHY These data demonstrate that the delayed and steeper decline in cardiovascular function observed in aging females can be modeled in aging mice. Moreover, the mechanisms driving vascular and cardiac aging phenotypes are distinct between males and females. Mineralocorticoid receptors in smooth muscle cells play a significant role in cardiovascular aging in both sexes; however, they do so by distinct mechanisms. Overall, these findings suggest that sex-specific therapies may be necessary to retard the aging process and improve cardiovascular disease outcomes in the aging population.